Literature DB >> 18174698

Endocrine consequences of adult traumatic brain injury.

Lucy Ann Behan1, Amar Agha.   

Abstract

BACKGROUND: Traumatic brain injury (TBI) is the most common cause of death and disability in young adults living in industrialised countries. Over the last few years, there has been an increasing awareness that hypopituitarism can complicate TBI in a significant proportion of survivors: at least 25% of TBI survivors develop one or more pituitary hormone deficiencies. This remarkably high frequency has changed the traditional concept that hypopituitarism was a rare complication of TBI and suggests that most cases of posttraumatic hypopituitarism remain undiagnosed and untreated in clinical practice. It is therefore reasonable to infer that posttraumatic hypopituitarism may make an important contribution to the high rates of physical and neuropsychiatric morbidity in patients with head injury.
CONCLUSIONS: There is clearly a need for identification as well as appropriate and timely management of hormone deficiencies in TBI patients to reduce morbidity, aid recovery and rehabilitation and avoid the long-term complications of pituitary failure. Copyright (c) 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2007        PMID: 18174698     DOI: 10.1159/000110466

Source DB:  PubMed          Journal:  Horm Res        ISSN: 0301-0163


  12 in total

1.  Combination Therapies for Traumatic Brain Injury: Retrospective Considerations.

Authors:  Susan Margulies; Gail Anderson; Fahim Atif; Jerome Badaut; Robert Clark; Philip Empey; Maria Guseva; Michael Hoane; Jimmy Huh; Jim Pauly; Ramesh Raghupathi; Stephen Scheff; Donald Stein; Huiling Tang; Mona Hicks
Journal:  J Neurotrauma       Date:  2015-08-06       Impact factor: 5.269

Review 2.  Endocrine changes after pediatric traumatic brain injury.

Authors:  Susan R Rose; Bethany A Auble
Journal:  Pituitary       Date:  2012-09       Impact factor: 4.107

3.  Candidate genes for panhypopituitarism identified by gene expression profiling.

Authors:  Amanda H Mortensen; James W MacDonald; Debashis Ghosh; Sally A Camper
Journal:  Physiol Genomics       Date:  2011-08-09       Impact factor: 3.107

4.  Apelin Receptor Signaling Protects GT1-7 GnRH Neurons Against Oxidative Stress In Vitro.

Authors:  Hatice Burcu Şişli; Taha Bartu Hayal; Selinay Şenkal; Binnur Kıratlı; Derya Sağraç; Selin Seçkin; Murat Özpolat; Fikrettin Şahin; Bayram Yılmaz; Ayşegül Doğan
Journal:  Cell Mol Neurobiol       Date:  2020-09-28       Impact factor: 5.046

Review 5.  Epidemiology, diagnosis, and treatment of male hypogonadotropic hypogonadism.

Authors:  A Lenzi; G Balercia; A Bellastella; A Colao; A Fabbri; C Foresta; M Galdiero; L Gandini; C Krausz; G Lombardi; F Lombardo; M Maggi; A Radicioni; R Selice; A A Sinisi; G Forti
Journal:  J Endocrinol Invest       Date:  2009-12-01       Impact factor: 4.256

6.  Progesterone with vitamin D affords better neuroprotection against excitotoxicity in cultured cortical neurons than progesterone alone.

Authors:  Fahim Atif; Iqbal Sayeed; Tauheed Ishrat; Donald G Stein
Journal:  Mol Med       Date:  2009-06-26       Impact factor: 6.354

7.  Hypopituitarism and brain injury: recent advances in screening and management.

Authors:  Johanna Pickel; Harald J Schneider; Günter K Stalla
Journal:  F1000 Med Rep       Date:  2009-08-17

8.  High prevalence of chronic pituitary and target-organ hormone abnormalities after blast-related mild traumatic brain injury.

Authors:  Charles W Wilkinson; Kathleen F Pagulayan; Eric C Petrie; Cynthia L Mayer; Elizabeth A Colasurdo; Jane B Shofer; Kim L Hart; David Hoff; Matthew A Tarabochia; Elaine R Peskind
Journal:  Front Neurol       Date:  2012-02-07       Impact factor: 4.003

Review 9.  Alcohol's Burden on Immunity Following Burn, Hemorrhagic Shock, or Traumatic Brain Injury.

Authors:  Patricia E Molina; Paige S Katz; Flavia Souza-Smith; Stephen M Ford; Sophie X Teng; Tracy Y Dodd; John K Maxi; Jacques P Mayeux
Journal:  Alcohol Res       Date:  2015

10.  Endocrine Dysfunction Following Stroke.

Authors:  Fei Wang; Ming-Ying Luo; Lei Zhou; Li Yang; Giuseppe Lanzino; Heng-Jui Chang; George C Wellman
Journal:  J Neuroimmune Pharmacol       Date:  2020-07-03       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.